Polidocanol - BioForm Medical/Chemische Fabrik Kreussler & Co

Drug Profile

Polidocanol - BioForm Medical/Chemische Fabrik Kreussler & Co

Alternative Names: Aethoxysklerol; Asclera

Latest Information Update: 16 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chemische Fabrik Kreussler & Co
  • Class Polyethylene glycols; Sclerosants; Vascular disorder therapies
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Varicose veins

Most Recent Events

  • 15 Jul 2010 Launched for Varicose veins in USA (IV)
  • 30 Mar 2010 US FDA approves polidocanol injection for the treatment of varicose veins
  • 19 Feb 2010 BioForm Medical has been acquired by Merz Pharma; they are now operating as a wholly-owned subsidiary under the name Merz Aesthetics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top